Cimicoxib

CAS No. 265114-23-6

Cimicoxib( UR-8880 | UR8880 | UR8880 | Cimicoxib )

Catalog No. M27969 CAS No. 265114-23-6

Cimicoxib is a potent and selective inhibitor of COX-2 with anti-inflammatory and analgesic activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 48 Get Quote
5MG 68 Get Quote
10MG 102 Get Quote
25MG 169 Get Quote
50MG 255 Get Quote
100MG 380 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Cimicoxib
  • Note
    Research use only, not for human use.
  • Brief Description
    Cimicoxib is a potent and selective inhibitor of COX-2 with anti-inflammatory and analgesic activity.
  • Description
    Cimicoxib is a potent and selective inhibitor of COX-2 with anti-inflammatory and analgesic activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    UR-8880 | UR8880 | UR8880 | Cimicoxib
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    265114-23-6
  • Formula Weight
    381.81
  • Molecular Formula
    C16H13ClFN3O3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (327.39 mM)
  • SMILES
    COc1ccc(cc1F)-c1c(Cl)ncn1-c1ccc(cc1)S(N)(=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ema M, et al. Screening study for repeated dose and reproductive/developmental toxicity of rubber accelerator, N,N-dicyclohexyl-2-benzothiazolesulfenamide, in rats. Drug Chem Toxicol. 2007;30(3):167-80.
molnova catalog
related products
  • Serplulimab

    Serplulimab (HLX 10) is a humanized monoclonal anti-antibody to PD-1. Serplulimab has antitumor activity and can be used in small cell lung cancer and esophageal squamous cell carcinoma.

  • Resveratrol

    Resveratrol is a phytoalexin produced naturally by several plants with anti-Y, anti-inflammatory, blood-sugar-lowering and other beneficial cardiovascular effects.

  • Naproxen

    Naproxen is a COX inhibitor for COX-1 and COX-2 with IC50 of 8.7 μM and 5.2 μM, respectively.